The new pharmaceutical enterprise business model requires dramatic changes in drug discovery, clinical research, and clinical and commercial manufacturing.

The ARC survey, assessment and report provided a roadmap for systems that support the next level of business performance so they can continue to be competitive.

ARC advises a speciality chemicals company with their manufacturing systems architecture and future roadmap.

ARC was engaged to perform a project implementation audit by a leading beverage company.